GSE109350
Collagen 22a1 is a TGFß early response gene in human skin that mediates the fibroblast to myofibroblast transition
Systemic sclerosis (SSc) is a complex multi-system autoimmune disease characterized by immune dysregulation, vasculopathy, and organ fibrosis. Skin fibrosis causes high morbidity and impaired quality of life in affected individuals. In this study, we identified the COL22a1 gene associated with the pathogenesis of skin fibrosis through high-throughput RNA sequencing of human skin in organ culture. The expression levels of COL22a1 were significantly increased by TGFß in ex vivo human skin tissues and normal human skin fibroblasts, while other fibrosis growth factors such as IL-6 and bleomycin modestly increased COL22a1 expression. Overall design: Skin samples were cultured with TGFß (10 ng/ml) or a vehicle control. Skin tissues were harvested at 48 hours.